🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of the study is to determine the extent of cyclosporine microem...
Status
Completed
Location
Multiple Locations
Start Date
2004-09
Trial ID
NCT00170794
Treatments Being Tested
This study will assess whether a calcineurin inhibitor (CNI)-free regimen w...
Status
Completed
Location
Novartis Investigative Site
Start Date
2009-02-24
Trial ID
NCT00862979
In the present study, the investigators propose a conversion scheme with 50...
Status
Terminated
Location
Hospital São João de Deus/Fundação Geraldo Corrêa
Start Date
2013-03
Trial ID
NCT01609673
Treatments Being Tested
The purpose of this study was to determine whether an early Calcineurin Inh...
Status
Completed
Location
Novartis Investigative Site
Start Date
2010-08-09
Trial ID
NCT01114529
Treatments Being Tested
This study will assess safety and efficacy of AEB071 combined with everolim...
Status
Completed
Location
Argentina
Start Date
2007-07
Trial ID
NCT00504543
The purpose of this study was to compare the safety and efficacy of three i...
Status
Completed
Location
Novartis
Start Date
2005-10
Trial ID
NCT00251004
Treatments Being Tested
Study efficacy of everolimus on course of uveitis: * obtain quiescence of ...
Status
Completed
Location
Department of Ophthalmology at St. Franziskus Hospital
Start Date
2007-11
Trial ID
NCT00803816
Treatments Being Tested
This study is designed to evaluate efficacity and safety of everolimus or (...
Status
Completed
Location
CHU Amiens
Start Date
2009-03
Trial ID
NCT01028092
Treatments Being Tested
To evaluate the safety and tolerability of early switch to everolimus from ...
Status
Completed
Location
Novartis Investigative Site,
Start Date
2006-09
Trial ID
NCT00464399
Treatments Being Tested
This extension study is designed to provide long-term safety and efficacy d...
Status
Completed
Location
Novartis
Start Date
2001-11
Trial ID
NCT00531440
Treatments Being Tested